MétaCan
Menu
Back to cohort
Record W4413336948 · doi:10.4252/wjsc.v17.i8.107076

Entering the era of living biopharmaceuticals for treating knee osteoarthritis: A systematic review and network meta-analysis

2025· review· en· W4413336948 on OpenAlexaboutno aff
Moaz Safwan, Mariam Safwan Bourgleh, Lubabah Baroudi, Aseel Almsned, Rawan Yousef N Albalawi, Batoul Aibour, Shahad AlFawaz, Safwan M Bourgleh, Khawaja Husnain Haider

Bibliographic record

VenueWorld Journal of Stem Cells · 2025
Typereview
Languageen
FieldMedicine
TopicOsteoarthritis Treatment and Mechanisms
Canadian institutionsnot available
Fundersnot available
KeywordsOsteoarthritisMedicineMeta-analysisAlternative medicinePathology

Abstract

fetched live from OpenAlex

BACKGROUND Knee osteoarthritis (KOA) is a leading cause of arthritis-related morbidity. Mesenchymal stem cells (MSCs), as living biopharmaceuticals, have emerged as a potential treatment option due to their anti-inflammatory and immunomodulatory properties. AIM To compare the safety and efficacy of allogenic MSCs (AlloMSCs) vs autologous MSCs (AutoMSCs) in treating KOA in clinical settings. METHODS We conducted a systematic review and network meta-analysis to compare the safety and efficacy of AlloMSCs vs AutoMSCs in treating KOA. Our systematic search of four databases, including PubMed, Cochrane, Embase, and ClinicalTrials.gov, identified relevant randomized controlled trials (RCTs) reporting MSC-based treatment for KOA and reporting visual analog scale, Western Ontario and McMaster Universities Osteoarthritis scores, and adverse events. We assessed the methodological quality of the studies using the Cochrane Collaboration tool and calculated risk ratios (RRs) and weighted mean differences [with 95% confidence intervals (CIs)]. Our statistical analyses used the R-Studio network meta-packages (version 2023.12.0). The study protocol was pre-registered on the International Prospective Register of Systematic Reviews (ID: CRD42024590866). RESULTS Nineteen RCTs involving 1216 patients with KOA met the inclusion criteria of the study. The network meta-analysis showed that AlloMSCs gave a significant reduction in visual analog scale scores by 14.91 points (95%CI: -24.52 to -5.30) vs 12.95 points with AutoMSCs (95%CI: -24.42 to -1.48). For Western Ontario and McMaster Universities Osteoarthritis score, AlloMSCs led to a significant reduction of 23.12 points (95%CI: -31.15 to -15.10) compared with 12.45 points using AutoMSCs (95%CI: -19.31 to -5.59), thus revealing a significant improvement with AlloMSCs (weighted mean difference: -10.62, 95%CI: -21.23 to -0.11). Additionally, AutoMSCs treatment showed a higher risk of joint-related adverse events (RR = 1.39, 95%CI: 1.07-1.79) compared with AlloMSCs (RR = 1.13, 95%CI: 1.01-1.25). CONCLUSION AlloMSCs may offer superior clinical outcomes with a lower risk of adverse events compared with AutoMSCs in the treatment of KOA. However, the need for further RCTs directly comparing the two MSC types is crucial to validate this data, underscoring the importance of our findings in this field.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.027
metaresearch head score (Gemma)0.059
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.027
Threshold uncertainty score0.142

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0270.059
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0210.037
Bibliometrics0.0090.010
Science and technology studies0.0010.001
Scholarly communication0.0040.002
Open science0.0020.002
Research integrity0.0030.002
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.062
GPT teacher head0.345
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueWorld Journal of Stem CellsSame topicOsteoarthritis Treatment and MechanismsFrench-language works237,207